Ceramide glycosylation potentiates cellular multidrug resistance

FASEB Journal

Volumn 15, Issue 3, 2001, Pages 719-730

  Liu, Yong Yu ^a   Han, Tie Yan ^a   Giuliano, Armando E ^a   Cabot, Myles C ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Antisense; Apoptosis; Breast cancer; Chemotherapy; Glucosylceramide synthase

Indexed keywords

CASPASE; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLUCOSYLCERAMIDE; GLYCOPROTEIN P; RHODAMINE 123; VINBLASTINE;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; EPITHELIOID CELL; GENE TARGETING; GLYCOSYLATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL SIZE; CERAMIDES; DNA, ANTISENSE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLUORESCENT DYES; GENETIC VECTORS; GLUCOSYLTRANSFERASES; GLYCOSYLATION; HUMANS; P-GLYCOPROTEIN; RHODAMINE 123; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS; VINCA;

EID: 0035079539     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0223com     Document Type: Article

References (65)

1. Functions of ceramide in coordinating cellular responses to stress
2. Regulation of ceramide production and apoptosis
3. Accumulation of glucosylceramides in multidrug-resistant cancer cells
4. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
5. Differential expression of sphingolipids in MRP1 overexpressing HT29 cells
6. 6-fold increased cell sensitivity to verocytotoxin: Role of p-glycoprotein in glycolipid synthesis
7. Glucosylceramide: A marker for multiple-drug resistant cancers
8. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
9. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells
10. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis
11. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance
12. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats
13. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis
14. Glucosylceramide synthase of mouse kidney: Further characterization with an improved assay method
15. Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting
16. Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis
17. Cell death: The significance of apoptosis
18. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
19. Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation
20. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo
21. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: Taxol and vinblastine modulate drug efflux
22. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells
23. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi
24. Apoptosis: A cell mechanism important for cytotoxic response to adriamycin and a lipid metabolic pathway that facilitates escape
25. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation
26. Biochemistry of multidrug resistance mediated by the multidrug transporter
27. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells
28. Clinical multidrug resistance in cancer: A multifactorial problem
29. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability
30. Immunohistochemical analysis of P-glycoprotein expression in breast cancer: Clinical correlations
31. Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients
32. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells
33. The role of ceramide in the cellular response to cytotoxic agents
34. Initiation of ionizing radiation-induced apoptosis: DNA damage-mediated or does ceramide have a role?
35. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
36. p53-dependent ceramide response to genotoxic stress
37. SDZ PSC 933, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthase and increase vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells
38. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide
39. Ceramide in the eukaryotic stress response
40. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation: Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
41. Glucosylceramides stimulate murine epidermal hyperproliferation
42. Stimulation of liver growth and DNA synthesis by glucosylceramide
43. Non-Hodgkin's lymphoma associated with Gaucher's disease
44. Changes in composition of newly synthesized sphingolipids of HeLa cells during the cell cycle-suppression of sphingomyelin and higher-glycosphingolipid synthesis and accumulation of ceramide and glucosylceramide in mitotic cells
45. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase: Correlation with cyclin-dependent kinases
46. Glucosylceramide synthetase inhibitor, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells
47. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action
48. Reversal of adriamycin resistance with chimeric antiganglioside GM2 antibody
49. Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine
50. Down-regulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: Effects on cellular growth, melanogenesis, and dendricity
51. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells
52. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics
53. Chemotherapy by slowing glucosphingolipid synthesis
54. Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyl-transferase from embryonic chicken brain
55. Recent advances in the biochemistry of sphingolipidoses
56. Functional rafts in cell membranes
57. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains
58. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane
59. Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells
60. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells
61. Cancer-associated glycosphingolipid antigens: Their structure, organization, and function
62. A vital role for glycosphingolipid synthesis during development and differentiation
63. Effects of the glucosphingolipid synthesis inhibitor PDMP on lysosomes in cultured cells
64. Effects of glucosylceramide synthase inhibitor and ganglioside GQ1b on synchronous oscillations of intracellular Ca2+ in cultured cortical neurons
65. Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells